Course Information
5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

Le Méridien Delfina Santa Monica
Santa Monica, California
May 02, 2015

Download: [ PDF ]


Course Description

Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is an unusual tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, may only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 28 years of experience with treating patients with MPM and, in particular, lung-sparing therapies, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.

Target Audience

  • Pulmonary physicians who are frequently involved in patient workups
  • Medical oncologists who are frequently involved in patient therapy
  • Mesothelioma experts who want to learn/share experiences about lung-sparing therapies
  • Patients, family, friends who desire to learn more about the disease

Registration Information

Early enrollment is advised.

Online

To enroll click here

By Mail

Send the completed enrollment form to:

Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
Mesothelioma
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA at (310) 794-2624

By Phone

Use your MasterCard, VISA, American Express, or Discover. Call (310) 794-2620.

Registration Fees

Early registration fee (before April 17)

  • $150 Physicians
  • $100 Nurses
  • $50 Family & Patients
  • $25 Students*
  • $250 Legal Profession
Late registration fee (starting April 17)
  • $225 Physicians
  • $150 Nurses
  • $75 Family & Patients
  • $40 Students
  • $500 Legal Profession
*Must show student ID on-site

Refunds

Cancellations must be received in writing by April 2, 2015 and will be subject to a $75 processing fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.

Faculty

Course Chair

Robert B. Cameron, MD, FACS
Professor of Clinical Cardiothoracic Surgery and Surgical Oncology
Director, Comprehensive Mesothelioma Program
David Geffen School of Medicine at UCLA
Chief, Thoracic Surgery
West Los Angeles VA Medical Center
Los Angeles, California

International and Distinguished Faculty

Marc de Perrot, MD, MSc
Associate Professor of Surgery, University of Toronto
Director, Toronto Mesothelioma Research Program
Division of Thoracic Surgery
Toronto General Hospital
Toronto, Canada

J. Andrea McCart, MD, MSc, FRCS(C)
Associate Professor
Department of Surgery, University of Toronto
Toronto General Research Institute
Toronto, Canada

Shilpen Patel, MD, FACRO
Associate Professor, University of Washington Medical Center
Medical Director of the Clinical Outcomes Assessment Program/Foundation for Health Care Quality
Chief of Thoracic Radiation Oncology/Stereotactic Body Radiation Therapy Program Lead
Seattle, Washington

Walter Weder, MD
Professor of Surgery
Head, Division of Thoracic Surgery
University Hospital of Zürich
Zürich, Switzerland

Faculty

Clare Cameron
Executive Director
Pacific Heart, Lung, & Blood Institute
Los Angeles, California

Peter V. Chen, MD
Radiation Oncology
Hoag Family Cancer Institute
Newport Beach, California

Lien Hua-Feng, RN, MSN, NP-C
Nurse Practitioner
Pacific Mesothelioma Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California

Percy Lee, MD
Associate Professor
Chief, Thoracic Radiation Oncology
Director, Stereotactic Body Radiation Therapy Program
David Geffen School of Medicine at UCLA
Los Angeles, California

Mrs. Mia Lauter
Widow of Famed Actor Ed Lauter
Los Angeles, California

Olga Olevsky, MD
Health Sciences Assistant Clinical Professor
Santa Monica Oncology
David Geffen School of Medicine at UCLA
Santa Monica, California

Linda Reinstein
President/CEO and Co-Founder
Asbestos Disease Awareness Organization (ADAO)
Manhattan Beach, California

Raymond Wong, PhD
Research Scientist
Pacific Meso Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California

Program Agenda

Saturday, May 2, 2015

7:30 Registration and Breakfast
8:00 Welcome
Robert B. Cameron, MD, FACS
Morning Session I: Lung-Sparing Surgical Techniques
Moderator: Robert B. Cameron, MD, FACS
8:15 "Extending" Lung-Sparing Surgery to Include the Diaphragm and Pericardium: The Pros and Cons
Robert B. Cameron, MD, FACS
8:50 Transition from EPP to P/D, One Surgeon's Experience
Walter Weder, MD
9:25 Discussion
9:40 Break
Morning Session II: Lung-Sparing Adjuvant Therapies
Moderator: Percy Lee, MD
9:55 Surgery for Mesothelioma after Radiation Therapy: Present and Future
Marc de Perrot, MD, MSc
10:30 The Spectrum of Radiation: What "Flavor" to Choose?
Shilpen Patel, MD, FACRO
11:05 Postoperative Tomotherapy: Tissue Targeting and Toxicity
Peter V. Chen, MD and Percy Lee, MD
11:40 Systemic Therapy for Malignant Pleural Mesothelioma: An Update on Immunotherapy, Cancer Stem Cells, and More
Olga Olevsky, MD
12:15 Discussion
12:30 Lunch
Afternoon Session I: Potential Future Adjuvant Therapies
Moderators: Robert B. Cameron, MD, FACS and Raymond Wong, PhD
1:30 Combination Oncolytic Virotherapy and Surgical Debulking for Peritoneal Mesothelioma: Preclinical Data
J. Andrea McCart, MD, MSc, FRCS(C)
2:00 Tumor Vaccines
TBD
2:30 Strategies to Enhance Immune-Based Therapies for Mesothelioma
Raymond Wong, PhD
3:00 Discussion
3:15 Break
Afternoon Session II: Supportive Therapies
Moderators: Clare Cameron
3:30 Mesothelioma and the Internet: Big Business, Confusion, and Desperation
Lien Hua-Feng, RN, MSN, NP-C
3:45 The Fight Against Asbestos (and Mesothelioma): The Human Cost of Inaction
Linda Reinstein
4:00 Mesothelioma and the Hollywood Film Industry
Clare Cameron
4:15 My Mesothelioma Journey
Mia Lauter
4:30 Discussion
4:45 Concluding Remarks
Robert B. Cameron, MD, FACS
5:00 Adjourn

Objectives

At the completion of this course, participants should be able to:

  • understand the role of each modality in multidisciplinary therapies, including surgery, radiation, and chemotherapy
  • discuss the indications and contra-indications for surgery
  • recognize the pros and cons of lung-sparing surgery for MPM
  • understand the need for chronic treatment for MPM
  • identify the various types of radiation and their potential role in adjuvant therapy

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Miscellaneous

Conference Location

Le Méridien Delfina Santa Monica
530 Pico Blvd.
Santa Monica, CA 90405
310-399-9344

Accommodations

If you wish to stay at the hotel, please call reservations at 888-627-8532.

Parking

Valet parking is $10. (Please inform the attendant that you are attending the course to receive this rate.)